Cargando…

Vestigial-like 3 is an inhibitor of adipocyte differentiation

Adipose differentiation is a complex process controlled by a network of transcription factors and co-regulators. We compared the global gene expression patterns of adipogenic and nonadipogenic clones of 3T3-F442A preadipocytes and identified the transcriptional cofactor, vestigial-like 3 (Vgll3), as...

Descripción completa

Detalles Bibliográficos
Autores principales: Halperin, Daniel S., Pan, Calvin, Lusis, Aldons J., Tontonoz, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541706/
https://www.ncbi.nlm.nih.gov/pubmed/23152581
http://dx.doi.org/10.1194/jlr.M032755
_version_ 1782255402547675136
author Halperin, Daniel S.
Pan, Calvin
Lusis, Aldons J.
Tontonoz, Peter
author_facet Halperin, Daniel S.
Pan, Calvin
Lusis, Aldons J.
Tontonoz, Peter
author_sort Halperin, Daniel S.
collection PubMed
description Adipose differentiation is a complex process controlled by a network of transcription factors and co-regulators. We compared the global gene expression patterns of adipogenic and nonadipogenic clones of 3T3-F442A preadipocytes and identified the transcriptional cofactor, vestigial-like 3 (Vgll3), as an inhibitor of adipogenesis. Vgll3 expression is down-regulated during terminal adipocyte differentiation in vitro and negatively correlates with weight and total fat mass in vivo. Furthermore, enforced Vgll3 expression inhibits the differentiation of preadipocytes in vitro, whereas shRNA-mediated knockdown of Vgll3 expression promotes differentiation. Expression of Vgll3 promoted the expression of genes associated with bone and chondrocyte formation, suggesting that Vgll3 participates in the decision of mesenchymal cells to proceed down the adipocyte, bone, or cartilage lineages. The elucidation of factors involved in specification of the adipocyte phenotype may aid in the identification of new strategies for the treatment of metabolic disease.
format Online
Article
Text
id pubmed-3541706
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-35417062013-08-27 Vestigial-like 3 is an inhibitor of adipocyte differentiation Halperin, Daniel S. Pan, Calvin Lusis, Aldons J. Tontonoz, Peter J Lipid Res Research Articles Adipose differentiation is a complex process controlled by a network of transcription factors and co-regulators. We compared the global gene expression patterns of adipogenic and nonadipogenic clones of 3T3-F442A preadipocytes and identified the transcriptional cofactor, vestigial-like 3 (Vgll3), as an inhibitor of adipogenesis. Vgll3 expression is down-regulated during terminal adipocyte differentiation in vitro and negatively correlates with weight and total fat mass in vivo. Furthermore, enforced Vgll3 expression inhibits the differentiation of preadipocytes in vitro, whereas shRNA-mediated knockdown of Vgll3 expression promotes differentiation. Expression of Vgll3 promoted the expression of genes associated with bone and chondrocyte formation, suggesting that Vgll3 participates in the decision of mesenchymal cells to proceed down the adipocyte, bone, or cartilage lineages. The elucidation of factors involved in specification of the adipocyte phenotype may aid in the identification of new strategies for the treatment of metabolic disease. The American Society for Biochemistry and Molecular Biology 2013-02 /pmc/articles/PMC3541706/ /pubmed/23152581 http://dx.doi.org/10.1194/jlr.M032755 Text en Copyright © 2013 by the American Society for Biochemistry and Molecular Biology, Inc. http://creativecommons.org/licenses/by-nc/3.0/ Author's Choice—Final version full access. Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) applies to Author Choice Articles
spellingShingle Research Articles
Halperin, Daniel S.
Pan, Calvin
Lusis, Aldons J.
Tontonoz, Peter
Vestigial-like 3 is an inhibitor of adipocyte differentiation
title Vestigial-like 3 is an inhibitor of adipocyte differentiation
title_full Vestigial-like 3 is an inhibitor of adipocyte differentiation
title_fullStr Vestigial-like 3 is an inhibitor of adipocyte differentiation
title_full_unstemmed Vestigial-like 3 is an inhibitor of adipocyte differentiation
title_short Vestigial-like 3 is an inhibitor of adipocyte differentiation
title_sort vestigial-like 3 is an inhibitor of adipocyte differentiation
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541706/
https://www.ncbi.nlm.nih.gov/pubmed/23152581
http://dx.doi.org/10.1194/jlr.M032755
work_keys_str_mv AT halperindaniels vestigiallike3isaninhibitorofadipocytedifferentiation
AT pancalvin vestigiallike3isaninhibitorofadipocytedifferentiation
AT lusisaldonsj vestigiallike3isaninhibitorofadipocytedifferentiation
AT tontonozpeter vestigiallike3isaninhibitorofadipocytedifferentiation